Voyager Digital Holdings (VGX) 

Class Action & Lead Plaintiff Deadline: January 10, 2023

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Defendants Stephen Ehrlich, Gerard Hanshe, David Brosgol, Janice Barrilleaux, Philip Eytan, Jarrett Lilien, and Brian Brooks (collectively, “Defendants”) on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased so-called Voyager Financial Products, including Voyager Earn Accounts and/or VGX Tokens (collectively, “Voyager”) from January 1, 2020 and November 9, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case.

 

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

 

The complaint alleges that Defendants violated provisions of the Securities Act by selling non-exempt securities without registering them. The complaint alleges that Defendants participated in Voyager’s failure to register the Voyager Financial Products. After plaintiffs and class members purchased Voyager Financial Products, the complaint alleges that Voyager suspended withdrawals from its platform.

 

A class action lawsuit has already been filed. You can review a copy of the Complaint and sign the certification form or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you purchased Voyager Financial Products, including Voyager Earn Accounts and/or VGX Tokens you have until January 10, 2023, to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

 

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.  The firm has recovered hundreds of millions of dollars for investors nationwide.  Attorney advertising. Prior results do not guarantee similar outcomes.